These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 17408138

  • 1. [The current approach to hyper-sialorrhea].
    Defossez W.
    Rev Belge Med Dent (1984); 2006; 61(3):173-9. PubMed ID: 17408138
    [Abstract] [Full Text] [Related]

  • 2. Sialorrhea: a management challenge.
    Hockstein NG, Samadi DS, Gendron K, Handler SD.
    Am Fam Physician; 2004 Jun 01; 69(11):2628-34. PubMed ID: 15202698
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of sialorrhea in patients under long-term ventilation].
    Winterholler M.
    Pneumologie; 2008 Mar 01; 62 Suppl 1():S39-42. PubMed ID: 18317983
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of drooling in patients with parkinsonism].
    van Onna M, van Laar T.
    Ned Tijdschr Geneeskd; 2010 Mar 01; 154():A2282. PubMed ID: 21083950
    [Abstract] [Full Text] [Related]

  • 5. An evidence-based approach to the child who drools saliva.
    Little SA, Kubba H, Hussain SS.
    Clin Otolaryngol; 2009 Jun 01; 34(3):236-9. PubMed ID: 19531173
    [Abstract] [Full Text] [Related]

  • 6. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
    Møller E, Karlsborg M, Bardow A, Lykkeaa J, Nissen FH, Bakke M.
    Acta Odontol Scand; 2011 May 01; 69(3):151-7. PubMed ID: 21198339
    [Abstract] [Full Text] [Related]

  • 7. The management of drooling in adults with neurological conditions.
    Squires N, Wills A, Rowson J.
    Curr Opin Otolaryngol Head Neck Surg; 2012 Jun 01; 20(3):171-6. PubMed ID: 22487791
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
    Khan WU, Campisi P, Nadarajah S, Shakur YA, Khan N, Semenuk D, McCann C, Roske L, McConney-Ellis S, Joseph M, Parra D, Amaral J, John P, Temple M, Connolly B.
    Arch Otolaryngol Head Neck Surg; 2011 Apr 01; 137(4):339-44. PubMed ID: 21242533
    [Abstract] [Full Text] [Related]

  • 10. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
    Formeister EJ, Dahl JP, Rose AS.
    Int J Pediatr Otorhinolaryngol; 2014 Aug 01; 78(8):1387-92. PubMed ID: 24974144
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
    Vaile L, Finlay F.
    Arch Dis Child; 2006 Oct 01; 91(10):862-3. PubMed ID: 16990361
    [No Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
    Santamato A, Panza F, Solfrizzi V, Frisardi V, Ranieri M, Fiore P.
    J Rehabil Med; 2008 Nov 01; 40(10):882-3. PubMed ID: 19242630
    [No Abstract] [Full Text] [Related]

  • 14. Controlling sialorrhoea: a review of available treatment options.
    Potulska A, Friedman A.
    Expert Opin Pharmacother; 2005 Aug 01; 6(9):1551-4. PubMed ID: 16086642
    [Abstract] [Full Text] [Related]

  • 15. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
    Nóbrega AC, Rodrigues B, Torres AC, Enzo A, Melo A.
    J Neurol Sci; 2007 Feb 15; 253(1-2):85-7. PubMed ID: 17229441
    [Abstract] [Full Text] [Related]

  • 16. Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence.
    Molloy L.
    Curr Opin Neurol; 2007 Aug 15; 20(4):493-8. PubMed ID: 17620887
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG.
    Mov Disord; 2006 May 15; 21(5):704-7. PubMed ID: 16440332
    [Abstract] [Full Text] [Related]

  • 18. [Efficacy and safety of botulinum toxin in the treatment of sialorrhea in children with neurological disorders].
    García Ron A, Miranda MC, Garriga Braun C, Jensen Verón J, Torrens Martinez J, Diez Hanbino MP.
    An Pediatr (Barc); 2012 Oct 15; 77(4):289-91. PubMed ID: 22652186
    [No Abstract] [Full Text] [Related]

  • 19. Botulinum toxin for the treatment of sialorrhea: a meta-analysis.
    Vashishta R, Nguyen SA, White DR, Gillespie MB.
    Otolaryngol Head Neck Surg; 2013 Feb 15; 148(2):191-6. PubMed ID: 23112272
    [Abstract] [Full Text] [Related]

  • 20. Management of oral secretions in neurological disease.
    McGeachan AJ, Mcdermott CJ.
    Pract Neurol; 2017 Apr 15; 17(2):96-103. PubMed ID: 28188210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.